GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
KPV 10mg

KPV 10mg

KPV

CAS: 13147-31-4

$89.99$99.9910% OFFIn Stock

KPV (Lys-Pro-Val) is a C-terminal tripeptide of alpha-MSH with potent anti-inflammatory activity at MC1R and MC3R. Extensive IBD model data showing mucosal protection, reduced NF-kB activation, and colonic epithelial repair. 99.0% HPLC purity.

Specifications

Vial Size10mg
FormLyophilized Powder
Purity99.0% HPLC
CAS13147-31-4
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

MC1R and MC3R agonism in intestinal epithelial cells and macrophages suppresses NF-kB signaling, reduces pro-inflammatory cytokine production (TNF-a, IL-6, IL-1b), and promotes mucosal barrier integrity.

Research FAQ

How does KPV relate to BPC-157 for gut research?

KPV primarily targets mucosal inflammation via MC1R/MC3R with strong IBD data. BPC-157 targets angiogenesis and mucosal integrity via VEGFR2/NO. They address gut health through complementary mechanisms.

Related Compounds